{
Hoffmann-La Roche AG

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-052025-04-051111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-052025-04-051111100
Download SVG
Download PNG
Download CSV

China's push for innovation amid tariffs and semiconductor challenges

The US and EU have imposed significant tariffs on Chinese electric vehicle imports, raising concerns about China's overcapacity in the sector. Meanwhile, MIC2025 aims to enhance China's renewable energy and biopharmaceutical industries, with notable advancements in solar cell production and drug development, despite challenges in semiconductors and machine tools. As the end of MIC2025 approaches, China is expected to focus on high-tech goals and strengthen its position in global supply chains.
@nature
United States Dollar AstraZeneca PLC Hoffmann-La Roche AG Pfizer Inc. USA CHN DEU Helen Chen Erik Baark Show more
Technology & Innovation, Market Report
15:39 20.11.2024

Roche receives approval for subcutaneous Ocrevus for multiple sclerosis treatment

Roche's Ocrevus has received approval from Swissmedic for a subcutaneous formulation, allowing for administration as a twice-yearly injection. Previously, the drug was only available as an intravenous infusion for treating relapsing and primary progressive multiple sclerosis. Following the announcement, Roche shares saw a slight increase of 0.12 percent, reaching 249.50 Swiss francs.
finanzen.ch
Swiss Franc Hoffmann-La Roche AG CHE
Healthcare, Market Report
12:25 20.11.2024

foreign medical firms forge partnerships to enhance healthcare in china

At the recent China International Import Expo, multinational medical firms forged partnerships with local entities to enhance China"s healthcare landscape. Notable collaborations included EssilorLuxottica"s agreements to improve optical product manufacturing, Boehringer Ingelheim"s initiative to advance ischemic stroke treatment, and Roche"s launch of a pediatric healthcare exchange platform. Additionally, Shanghai Henlius Biotech partnered with Saudi Arabia"s SVAX to expand its global reach and improve access to affordable medical solutions.
@ChinaDailyApp
United States Dollar Boehringer Ingelheim KG Shanghai Henlius Biotech, Inc. Hoffmann-La Roche AG Fosun Pharma EssilorLuxottica Société anonyme DEU SAU CHN Chrystel Barranger Zhang Wenjie Show more
Healthcare, News Article
02:09 20.11.2024

pharmaceutical industry struggles to improve access to medicine in low-income countries

Pharmaceutical companies are increasingly focusing on access to medicines in low-income countries, with Novartis leading the way by integrating access plans into 96% of its late-stage drug projects. However, many companies still prioritize the US market, resulting in limited availability of essential medicines globally. Roche aims to double patient treatment numbers in low-income regions by 2026, yet significant gaps in transparency and patient reach persist across the industry.
SWI swissinfo.ch
Bristol-Myers Squibb Company GSK plc Hoffmann-La Roche AG AbbVie Inc. Sanofi Novo Nordisk A/S Novartis AG Johnson & Johnson Pfizer Inc. GBR CHE NLD Jayasree Iyer Sabastine Wakdok Show more
Healthcare, Market Report
14:30 19.11.2024

regenerative medicine market projected to reach 349 billion by 2033

The global regenerative medicine market is projected to grow from USD 31.90 billion in 2023 to USD 349.93 billion by 2033, with a CAGR of 27.06%. Cell therapy leads in market share, while musculoskeletal conditions are expected to grow the fastest. North America dominates the market due to advanced healthcare infrastructure and increased funding for research and development.
Spherical Insights
United States Dollar Novartis AG Hoffmann-La Roche AG Johnson & Johnson ReNeuron Pfizer Inc. USA GBR AUS KOR CHN IND BRA ITA MEX FRA ESP ZAF JPN DEU ARE CAN Dr. Samuel Lynch Samuel Lynch Pfizer Lynch Johnson & Johnson Show more
Healthcare, Market Report
04:37 19.11.2024

Merck"s under-the-skin Keytruda shows promise in Phase 3 trial

Merck"s experimental under-the-skin injection of Keytruda demonstrated comparable characteristics to the intravenous version in a Phase 3 trial, prompting plans for discussions with regulators. With the IV formulation"s U.S. patent set to expire in 2028, Merck aims to sustain revenue from its leading cancer drug, which generated nearly $22 billion in sales in 2024. The subcutaneous version could offer greater convenience and is protected by new patents, but timely approval is crucial to fend off emerging biosimilar competition.
BioPharma Dive
United States Dollar Merck & Co., Inc. Celltrion Bristol-Myers Squibb Company Hoffmann-La Roche AG Amgen Inc. Samsung Bioepis Sandoz Group AG USA Show more
Healthcare, Market Report
01:00 19.11.2024

healthcare nanotechnology market projected to reach 391 billion by 2028

The global Healthcare Nanotechnology Market is projected to grow from USD 205.85 billion in 2021 to USD 391.04 billion by 2028, with a CAGR of 9.6%. The comprehensive report analyzes key growth factors, competitive landscape, and regional dynamics, featuring major players like Amgen, Roche, and Pfizer. It includes detailed insights on market segmentation, trends, and strategic factors influencing the industry.
openPR.com
Amgen Inc. Hoffmann-La Roche AG Teva Pharmaceuticals Abbott UCB SA CAN GBR FRA ITA JPN AUS DEU CHN MEX ZAF USA BRA ESP IND Joe Biden Donald Trump Allan Carter Show more
Finance & Economy, Market Report
21:00 18.11.2024

health stocks plunge after trump appoints vaccine skeptic as health secretary

Health stocks have plummeted following Donald Trump's appointment of vaccine skeptic Robert F. Kennedy Jr. as health secretary, with Moderna, Pfizer, and GSK experiencing significant losses. The decline has affected US-exposed European healthcare stocks as well, amid growing uncertainty in the vaccine industry. Analysts have downgraded their outlooks on vaccine stocks, reflecting concerns over Kennedy's stance on vaccines and potential policy changes.
Markets Insider
Moderna, Inc. Novavax, Inc. GSK plc Novo Nordisk A/S Pfizer Inc. Hoffmann-La Roche AG USA Robert F. Kennedy Jr. Donald Trump Emmanuel Papadakis Show more
Regulatory & Legal, Market Report
19:16 15.11.2024

swiss stock market faces downturn amid us interest rate concerns

The Swiss stock market remains in a bearish trend, with the SMI Guiding Values Index down 1.08% to 8174.97 points, influenced by concerns over potential U.S. interest rate hikes. Major banks like UBS and Credit Suisse faced significant losses, while defensive stocks like Nestlé and Novartis attempted to mitigate the downturn. Kudelski saw a positive turn with a court victory against China's Gotech, while Adienne announced plans to enter the stock market without further details.
TicinoNews
United States Dollar Richemont DNS Inc. Julius Bär Stiftung Novartis AG Hoffmann-La Roche AG Swiss Life Holding AG Swatch AG ADIENNE SA Credit Suisse Anlagestiftung Gotech Swiss Re AG Zurich Insurance Group AG ABB Ltd Geberit AG UBS AG Kudelski SA LafargeHolcim Ltd. Nestlé S.A. Adecco Group AG CHE Eric Rosengren Show more
TradFi, Market Report
18:34 15.11.2024

swiss stock exchange declines as investors react to us interest rate concerns

The Swiss stock exchange closed lower, with the SMI down 0.70% at 8206.20 points, following concerns over potential U.S. interest rate hikes. Major banks like UBS and Credit Suisse faced significant losses, while defensive stocks like Nestlé and Novartis attempted to mitigate the downturn. Market experts anticipate a turbulent period ahead after recent volatility in U.S. markets.
TicinoNews
Swiss Franc Richemont DNS Inc. Swisscom AG Julius Bär Stiftung Novartis AG Actelion Ltd. Hoffmann-La Roche AG Swiss Life Holding AG Swatch AG ADIENNE SA Credit Suisse Anlagestiftung Swiss Re AG Zurich Insurance Group AG SGS SA ABB Ltd Geberit AG UBS AG Syngenta AVC SA Kudelski SA LafargeHolcim Ltd. Nestlé S.A. Adecco Group AG Givaudan SA CHE Eric Rosengren Neel Kashkari Dennis Lockhart Show more
TradFi, Market Report
17:32 15.11.2024
Trending
Subcategory
Corporate News Industry Trends Startups & Entrepreneurship Retail and Consumer Goods Supply Chain Management Global Trade Developments Stock Market Updates Government Economic Policies Industry Mergers & Acquisitions Energy Sector Developments Workplace Trends Funding Rounds & Investments CEO Changes AI Applications Private Equity Deals Emerging Startups Fintech Startups AI Innovations Global Financial Events Central Bank Actions
Countries:
USA CHN IND ARE SAU JPN GBR SGP KOR AUS IDN VNM HKG MYS DEU ISR CAN TWN TUR BGD
Companies:
Apple Inc. Google Inc. Tesla, Inc. Amazon.com, Inc. Microsoft Corporation Tesmec S.p.A. Alphabet Inc. OpenAI ERC USD Walmart Inc. SWIGGY LIMITED TENCENT NVIDIA Corporation Foxconn Technology Co., Ltd. Hollywood Bowl Group PLC NASDAQ Composite Wise plc Mastercard Inc Bose Corporation Mistral 1 Fast Retailing Co., Ltd.
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro Japanese Yen British Pound Sterling United Arab Emirates Dirham Vietnamese Đồng South Korean Won New Zealand Dollar Saudi Riyal Thai Baht Australian Dollar Indonesian Rupiah Singapore Dollar Omani Rial Bahraini Dinar Qatari Riyal Algerian Dinar Egyptian Pound
People:
Donald Trump Elon Musk Asmaa Naga Basma Bushnak Maha Taibah Ursula von der Leyen Hossam Ahmed Tasneem Islam Scott Bessent Joe Biden Sri Mulyani Mark Carney Howard Lutnick Yongqiang He Xi Jinping Aman Gupta Cristina Pitarch Mohamed Alkuwaiti Afeef Zaman Hareb Rashed

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.